Pricing Log in Create free account

Protara Therapeutics, Inc. (TARA) vs Yarrow Bioscience, Inc (YARW)

Protara Therapeutics, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Protara Therapeutics, Inc. and Yarrow Bioscience, Inc are of similar size ($147.2M and $135.9M). Protara Therapeutics, Inc. has the higher net margin (0.00% vs −3,881.5%) and the lower return on invested capital (−255.1% vs 0.00%). Across the 13 metrics below, Protara Therapeutics, Inc. leads on 8 and Yarrow Bioscience, Inc on 5.

Valuation

Metric TARA YARW Biotechnology median
P/E n/m n/m 10.60
P/S n/m 27.77 9.40
P/B 0.87 0.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.02 n/m 0.66
EV/Sales n/m 118.48 9.02
Earnings yield (58.70%) (138.76%) (32.88%)
Free cash flow yield (47.40%) (127.91%) (23.13%)

Profitability

Metric TARA YARW Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (4,134.44%) 0.00%
Net margin 0.00% (3,881.54%) 0.00%
Free cash flow margin 0.00% (3,513.07%) 0.00%
Return on equity (45.80%) (61.40%) (51.96%)
Return on assets (42.05%) (54.77%) (46.06%)
Return on invested capital (255.06%) 0.00% 0.00%

Growth

Metric TARA YARW Biotechnology median
Revenue growth (TTM) — 1.26% 6.76%
EPS growth (last fiscal year) 38.25% 32.26% 29.88%
Revenue growth, 5-year CAGR — (51.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TARA YARW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.97 15.26 4.97
Net debt to EBITDA 2.38 0.95 1.01

Dividend

Metric TARA YARW Biotechnology median
Dividend yield — 0.10% 0.41%
Payout ratio — — —

Size

Metric TARA YARW Biotechnology median
Market cap 135.92m 147.23m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack